Results 41 to 50 of about 120,642 (347)

Pharmacologic approaches against advanced glycation end products (ages) in diabetic cardiovascular disease [PDF]

open access: yes, 2015
Advanced Glycation End-Products (AGEs) are signaling proteins associated to several vascular and neurological complications in diabetic and non-diabetic patients.
Avtaar Singh, Sanjeet Singh   +6 more
core   +2 more sources

Skin advanced glycation end-products evaluation in infants according to the type of feeding and mother’s smoking habits

open access: yesSAGE Open Medicine, 2016
Objectives: This study was conducted to assess whether formula-fed infants had increased skin advanced glycation end-products compared with breastfed ones.
Giovanni Federico   +3 more
doaj   +1 more source

Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study [PDF]

open access: yes, 2005
We investigated the associations of pulse pressure (a measure of arterial stiffness) with the early glycation products hemoglobin A1c (HbA1c) and Amadori albumin and the advanced glycation end products pentosidine, Nepsilon-(carboxymethyl)lysine and ...
Bootsma, A.H.   +5 more
core   +4 more sources

Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction [PDF]

open access: yes, 2017
Hemoglobin glycation index (HGI), calculated as the difference between the observed value of HbA1 and the predicted HbA1c based on plasma glucose concentration, is a measure of the individual tendency toward non-enzymatic hemoglobin glycation which has ...
Andreozzi F   +6 more
core   +3 more sources

Advanced glycation end products as a biomarker for incisional hernia [PDF]

open access: yes, 2017
Background: Incisional hernia is one of the most frequent complications after abdominal surgery, with incidences up to 30%. A reliable biomarker for the prediction of this complication is lacking. Advanced glycosylation end products (AGEs), also known as
Cabezas, M.C.   +7 more
core   +4 more sources

Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases

open access: yesMolecules, 2022
As a critical molecule in the onset and sustainment of inflammatory response, the receptor for advanced glycation end products (RAGE) has a variety of ligands, such as advanced glycation end products (AGEs), S100/calcium granule protein, and high ...
Qing Yue   +5 more
semanticscholar   +1 more source

Leukocytes in type 1 diabetes mellitus: the changes they undergo and induce

open access: yesБіологічні студії, 2022
As leukocytes represent cellular and humoral immunity at the same time, they are a vital part of every immune process. This also stands for autoimmune processes and disorders, such as diabetes, specifically type 1 diabetes mellitus.
О. М. Kuchurka   +4 more
doaj   +1 more source

Adverse effects of advanced glycation end products on embryonal development [PDF]

open access: yes, 2008
We studied the effects of advanced glycation end products (AGEs), which are known to accumulate in patients with diabetes, autoimmune diseases, or those who smoke, on embryonal development.
Hao, Lin   +6 more
core   +1 more source

The critical role of methylglyoxal and glyoxalase 1 in diabetic nephropathy [PDF]

open access: yes, 2013
The discovery of increased formation of methylglyoxal (MG) by cell metabolism in high glucose concentration in vitro suggested possible relevance to diabetes and diabetes complications (1,2).
Rabbani, Naila, Thornalley, Paul J.
core   +1 more source

Advanced glycation end products promote osteoporosis by inducing ferroptosis in osteoblasts

open access: yesMolecular Medicine Reports, 2022
Advanced glycation end products (AGEs) have been widely reported to play an important role in osteoporosis (OP), particularly in diabetes-related OP.
Weiwei Ge   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy